Fresenius SE KGaA's (ETR:FRE) stock is up by a considerable 16% over the past three months. However, we decided to ...

Fresenius SE's restructuring and dividend reinstatement signal strong growth. Read why FSNUF stock may not be a long-term buy ...

The healthcare company said it had sold around 3.6% of Fresenius Medical Care’s share capital and that it would use the ...

Fresenius SE is seeking to raise about €1.1 billion ($1.2 billion) in a sale of shares in Fresenius Medical Care AG as well ...

Dialysis firm Fresenius Medical Care shares fell 7.8% after German healthcare group Fresenius SE sold part of its stake in ...

Kepler Capital analyst Oliver Reinberg maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) on March 13 and set a ...

Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) on March ...

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, released its 2024 Annual Report including its Sustainability Statement. By ...

Fresenius, the German health care group, sold 3.6% of the shares in kidney dialysis provider Fresenius Medical Care on Monday ...

The banker added: “Volatility will be higher for longer, and that can only help in the convertible space. The higher the ...

Fresenius SE FRE-2.57%decrease; red down pointing triangle said it raised around 1.1 billion euros ($1.15 billion) after selling part of its Fresenius Medical Care FME 0.45%increase; green up ...